NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Assessing RNA quality in postmortem human brain tissue.

Author(s): Chevyreva Ia, Faull RL, Green CR, Nicholson LF

Publication: Exp Mol Pathol, 2008, Vol. 84, Page 71

PubMed ID: 17959169 PubMed Review Paper? No

Purpose of Paper

This paper performed an RNA quality assessment in post mortem brain specimens form patients that differed with respect to age, gender, diagnosis, rapidity of death, and tissue pH to identify potential correlative relationships.

Conclusion of Paper

The authors report that brain pH correlated with RNA quality, and both were influenced by mode of death such that cases with faster deaths had higher brain pH and better quality RNA. Postmortem interval was observed to have a small effect on RNA quality. The quality of cerebellum RNA was not an ideal predictor of RNA quality elsewhere in the brain, but successfully served as an initial screen.

Studies

  1. Study Purpose

    This study performed an RNA quality assessment in post mortem brain specimens from patients that differed with respect to age, gender, diagnosis, rapidity of death, and tissue pH to identify potential correlative relationships, and to assess whether cerebellar RNA was predictive of RNA quality elsewhere in the brain.

    Summary of Findings:

    The authors report that brain pH correlated with RNA quality, and both were influenced by mode of death such that cases with faster deaths had higher brain pHs and better quality RNA. Mode of Death was rated "fast" or "slow" for each patient, but these terms were not defined. Longer postmortem intervals were observed to have a small deleterious effect on RNA quality. The quality of cerebellum RNA was not an optimal predictor of RNA quality elsewhere in the brain, but was successfully used as an initial screen. No relationship was observed between age of the patient, sex of the patient, or neurodegenerative disease status.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Alzheimer's Disease
    • Huntington's Disease
    • Autopsy
    • Not specified
    • Parkinson's Disease
    Platform:
    AnalyteTechnology Platform
    RNA Automated electrophoresis/Bioanalyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components pH Brain pH 5.3 - 6.2
    Preaquisition Postmortem interval 2 - 97 h
    Preaquisition Rapidity of death Fast
    Slow
    Biospecimen Acquisition Biospecimen location Cerebellum
    Caudate nucleus
    Motor cortex
    Medial temporal gyrus
    Preaquisition Patient gender Female
    Male
    Preaquisition Diagnosis/ patient condition Alzheimer's disease
    Huntington's disease
    Parkinson's disease
    Preaquisition Patient age 18 - 98 years

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...